Hamid Yazdianpour v. Safeblood Technologies, Inc.

779 F.3d 530
CourtCourt of Appeals for the Eighth Circuit
DecidedFebruary 27, 2015
Docket13-3586, 13-3632, 13-3639
StatusPublished
Cited by14 cases

This text of 779 F.3d 530 (Hamid Yazdianpour v. Safeblood Technologies, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hamid Yazdianpour v. Safeblood Technologies, Inc., 779 F.3d 530 (8th Cir. 2015).

Opinion

WOLLMAN, Circuit Judge.

Hamid Yazdianpour and Faisal Ali Mou-sa al Naqbi (Licensees), along with their limited liability company (the LLC), entered int%a licensing agreement with Safe-blood Technologies, Inc. (Safeblood Tech) for the exclusive rights to market patented technology overseas. Licensees later sued Safeblood Tech for breach of contract. Licensees also brought suit against Safe-blood Tech and its officers Charles Wor-den, Jr. (Worden Jr.), and Jim Limbird (collectively, Safeblood Group) and against patent inventor Charles Worden, Sr. (Wor-den Sr.), for fraud, constructive fraud, and violations of the Arkansas Deceptive Trade Practices Act (ADTPA), Ark.Code Ann. §§ 4-88-101 to -115. The district court dismissed the fraud claims at summary judgment. The remaining claims proceeded to trial and a jury found for Licensees, awarding them $786,000 in contract damages and no damages for violations of the ADTPA. The district court awarded Licensees an additional $144,150.40 in prejudgment interest.

Licensees appeal, arguing that the district court erred in dismissing their fraud claims at summary judgment, that a jury instruction on the ADTPA claim was erroneous, and that the jury returned an inconsistent verdict on the ADTPA claim. Safe-blood Group cross-appeals, arguing that Licensees lack standing, that the district court should have granted judgment as a matter of law on the ADTPA claim 1 and the entire case, and that prejudgment interest should not have been awarded. Worden Sr. filed a conditional cross-appeal, arguing that the district court should have granted his motion for judgment as a matter of law on the ADTPA claim. We reverse the grant of summary judgment on the common-law fraud claim and the award of prejudgment interest, and we affirm in all other respects.

I. Background

In December 2009, Licensees met with Limbird, Worden Jr., and Worden Sr. to discuss acquiring the exclusive rights to market certain Safeblood Tech products overseas. During the meeting, Worden Sr. told Licensees that the products used a patented formula that he had invented. Safeblood Tech and Licensees eventually entered into a licensing agreement. Although Worden Sr.’s patent was not mentioned in the original agreement, the parties contemplated that the patent rights would be assigned to Licensees, and the *535 agreement was later amended to make that explicit.

After signing the original licensing agreement, Yazdianpour emailed Limbird, asking about Worden Sr.’s relationship with another company and seeking clarification whether Licensees would be competing against that other company. Limbird explained that Worden Sr. had assigned the rights to U.S. Patent 6,303,-112 (“the patent”) to another company in the United States, but that Licensees would have the exclusive rights to market the patented technology in all other countries. Both Worden Sr. and Lim-bird sent emails to Yazdianpour advising him that to receive patent protection, Licensees would need to register the patent in each country in which they planned to do business. Worden Sr. also sent Yazdianpour an email with instructions for checking the status of the patent on the United States Patent and Trademark Office (USPTO) website. Safeblood Group and Worden Sr. assert that, had Licensees checked the USPTO website, it would have shown that Wor-den Sr. had assigned an interest in the patent to the other company in 1999 and that the other company had given Wor-den Sr. a security interest in the patent in 2002.

On February 15, 2010, Worden Sr. learned from his attorney that it was too late to register the patent in any other country and that the patent would be legally protected only in the United States. Worden Sr. relayed this information to Limbird, who then informed Worden Jr. Nevertheless, on February 18, 2010, Wor-den Sr. executed an agreement giving Saf-eblood Tech the exclusive rights to the patent outside the United States. On March 2, 2010, Safeblood Tech assigned these patent rights to Licensees, amending the original agreement to provide Licensees and the LLC with the exclusive rights to the patent outside the United States.

Licensees proceeded with plans to distribute and sell the products in the Middle East until May 2010, when they discovered that they would not be able to register the patent in any country. Thereafter, Licensees brought suit, alleging the claims set forth above. The district court granted summary judgment to Safeblood Group and Worden Sr. on the fraud claims, holding that Licensees could not establish justifiable reliance because public records available on the USPTO website showed that Safeblood Tech did not own the exclusive rights to the patented technology. The remaining claims proceeded to trial, where a jury found that Safeblood Tech had breached its contract with Licensees and that Safeblood Group and Worden Sr. had violated the ADTPA. Although Licensees requested $825,169.70 in damages, the jury, as set forth above, awarded $786,000 for the breach-of-contract claim and no damages for the ADTPA claim, followed by the district court’s award of $144,150.40 in prejudgment interest.

A magistrate judge received the jury’s verdict in place of the district judge who had presided over the case. After reading the verdict into the record, the magistrate judge dismissed the jury and stated that the district court would enter judgment based on the jury verdict. Court was then adjourned. More than a month later, Licensees filed a brief objecting to the ADT-PA verdict as inconsistent. Licensees raised the inconsistent-verdict issue again in their motion to amend the judgment, which the district court denied. Safeblood Group and Worden Sr. did not file a post-verdict motion for judgment as a matter of law or for a new trial.

II. Standing

As an initial matter, we hold that Licensees have standing to bring suit. Li *536 censees were parties to the contract that Safeblood Tech breached and were the parties allegedly harmed by the violation of the ADTPA and the defendants’ fraud. Despite Safeblood Group’s argument to the contrary, Licensees’ decision not to include the LLC as a plaintiff did not deprive them of Article III standing. See ABF Freight Sys., Inc. v. Int’l Bhd. of Teamsters, 645 F.3d 954, 959-61 (8th Cir.2011) (holding that a plaintiff who was a party to a breached contract had standing).

III. Fraud

Licensees argue that the district court erred in granting the defendants’ motions for summary judgment on the common-law fraud claim (having abandoned their constructive fraud claim). We review de novo a district court’s grant of summary judgment and its interpretation of state law, viewing the facts in the light most favorable to the nonmovant. Davidson & Schaaff, Inc. v. Liberty Nat’l Fire Ins. Co., 69 F.3d 868, 870 (8th Cir.1995).

Under Arkansas law, the elements of fraud are:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Seo v. Oh
District of Columbia, 2023
Omega SA v. 375 Canal, LLC
984 F.3d 244 (Second Circuit, 2021)
Jeffrey Klingenberg v. Vulcan Ladder USA, LLC
936 F.3d 824 (Eighth Circuit, 2019)
Simmons Foods, Inc. v. Industrial Risk Insurers
863 F.3d 792 (Eighth Circuit, 2017)
Sollenberger v. Sollenberger
173 F. Supp. 3d 608 (S.D. Ohio, 2016)
Ramthun v. Bryan Career College-Inc.
93 F. Supp. 3d 1011 (W.D. Arkansas, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
779 F.3d 530, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hamid-yazdianpour-v-safeblood-technologies-inc-ca8-2015.